Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells

Shashi Rajput, Prashanth Kumar Bhusetty Nagesh, Kaushik Kumar Dey, Ipsita Pal, Aditya Parekh, Mahitosh Mandal

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Aim: Thymoquinone (TQ), the predominant bioactive constituent of black seed oil (Nigella Sativa), has been shown to possess antineoplastic activity against multifarious tumors. However, the meticulous mechanism of TQ on Akt mediated survival pathway is still unrevealed in breast cancer. Here, we investigated TQ's mechanism of action against PI3K/Akt signaling and its downstream targets by modulating proteins translational machinery, leading to apoptosis in cancer cells. Main methods: MDA-MB-468 and T-47D cells were treated with TQ and evaluated for its anticancer activity through phase distribution and western blot. Modulatory effects of TQ on Akt were affirmed through kinase and drug potential studies. Key findings: Studies revealed G1 phase arrest till 24 h incubation with TQ while extended exposure showed phase shift to subG1 indicating apoptosis, supported by suppression of cyclin D1, cyclin E and cyclin dependent kinase inhibitor p27 expression. Immunoblot and membrane potential studies revealed mitochondrial impairment behind apoptotic process with upregulation of Bax, cytoplasmic cytochrome c and procaspase-3, PARP cleavage along with Bcl-2, Bcl-xL and survivin downregulation. Moreover, we construed the rationale behind mitochondrial dysfunction by examining the phosphorylation status of PDK1, PTEN, Akt, c-raf, GSK-3β and Bad in TQ treated cells, thus ratifying the involvement of Akt in apoptosis. Further, the consequential effect of Akt inhibition by TQ is proven by translational repression through deregulated phosphorylation of 4E-BP1, eIF4E, S6R and p70S6K. Significance: Our observations for the first time may provide a new insight for the development of novel therapies for Akt overexpressed breast cancer by TQ.

Original languageEnglish (US)
Pages (from-to)783-790
Number of pages8
JournalLife Sciences
Volume93
Issue number21
DOIs
StatePublished - Nov 13 2013

Fingerprint

Cyclin D1
Cells
Apoptosis
Breast Neoplasms
Phosphorylation
Cyclin-Dependent Kinase Inhibitor p27
70-kDa Ribosomal Protein S6 Kinases
Glycogen Synthase Kinase 3
Cyclin E
thymoquinone
G1 Phase
Phosphatidylinositol 3-Kinases
Phase shift
Caspase 3
Antineoplastic Agents
Membrane Potentials
Machinery
Seed
Tumors
Neoplasms

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells. / Rajput, Shashi; Bhusetty Nagesh, Prashanth Kumar; Dey, Kaushik Kumar; Pal, Ipsita; Parekh, Aditya; Mandal, Mahitosh.

In: Life Sciences, Vol. 93, No. 21, 13.11.2013, p. 783-790.

Research output: Contribution to journalArticle

Rajput, Shashi ; Bhusetty Nagesh, Prashanth Kumar ; Dey, Kaushik Kumar ; Pal, Ipsita ; Parekh, Aditya ; Mandal, Mahitosh. / Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells. In: Life Sciences. 2013 ; Vol. 93, No. 21. pp. 783-790.
@article{7614c369e694417d9f630fab3ceb91f1,
title = "Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells",
abstract = "Aim: Thymoquinone (TQ), the predominant bioactive constituent of black seed oil (Nigella Sativa), has been shown to possess antineoplastic activity against multifarious tumors. However, the meticulous mechanism of TQ on Akt mediated survival pathway is still unrevealed in breast cancer. Here, we investigated TQ's mechanism of action against PI3K/Akt signaling and its downstream targets by modulating proteins translational machinery, leading to apoptosis in cancer cells. Main methods: MDA-MB-468 and T-47D cells were treated with TQ and evaluated for its anticancer activity through phase distribution and western blot. Modulatory effects of TQ on Akt were affirmed through kinase and drug potential studies. Key findings: Studies revealed G1 phase arrest till 24 h incubation with TQ while extended exposure showed phase shift to subG1 indicating apoptosis, supported by suppression of cyclin D1, cyclin E and cyclin dependent kinase inhibitor p27 expression. Immunoblot and membrane potential studies revealed mitochondrial impairment behind apoptotic process with upregulation of Bax, cytoplasmic cytochrome c and procaspase-3, PARP cleavage along with Bcl-2, Bcl-xL and survivin downregulation. Moreover, we construed the rationale behind mitochondrial dysfunction by examining the phosphorylation status of PDK1, PTEN, Akt, c-raf, GSK-3β and Bad in TQ treated cells, thus ratifying the involvement of Akt in apoptosis. Further, the consequential effect of Akt inhibition by TQ is proven by translational repression through deregulated phosphorylation of 4E-BP1, eIF4E, S6R and p70S6K. Significance: Our observations for the first time may provide a new insight for the development of novel therapies for Akt overexpressed breast cancer by TQ.",
author = "Shashi Rajput and {Bhusetty Nagesh}, {Prashanth Kumar} and Dey, {Kaushik Kumar} and Ipsita Pal and Aditya Parekh and Mahitosh Mandal",
year = "2013",
month = "11",
day = "13",
doi = "10.1016/j.lfs.2013.09.009",
language = "English (US)",
volume = "93",
pages = "783--790",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "21",

}

TY - JOUR

T1 - Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells

AU - Rajput, Shashi

AU - Bhusetty Nagesh, Prashanth Kumar

AU - Dey, Kaushik Kumar

AU - Pal, Ipsita

AU - Parekh, Aditya

AU - Mandal, Mahitosh

PY - 2013/11/13

Y1 - 2013/11/13

N2 - Aim: Thymoquinone (TQ), the predominant bioactive constituent of black seed oil (Nigella Sativa), has been shown to possess antineoplastic activity against multifarious tumors. However, the meticulous mechanism of TQ on Akt mediated survival pathway is still unrevealed in breast cancer. Here, we investigated TQ's mechanism of action against PI3K/Akt signaling and its downstream targets by modulating proteins translational machinery, leading to apoptosis in cancer cells. Main methods: MDA-MB-468 and T-47D cells were treated with TQ and evaluated for its anticancer activity through phase distribution and western blot. Modulatory effects of TQ on Akt were affirmed through kinase and drug potential studies. Key findings: Studies revealed G1 phase arrest till 24 h incubation with TQ while extended exposure showed phase shift to subG1 indicating apoptosis, supported by suppression of cyclin D1, cyclin E and cyclin dependent kinase inhibitor p27 expression. Immunoblot and membrane potential studies revealed mitochondrial impairment behind apoptotic process with upregulation of Bax, cytoplasmic cytochrome c and procaspase-3, PARP cleavage along with Bcl-2, Bcl-xL and survivin downregulation. Moreover, we construed the rationale behind mitochondrial dysfunction by examining the phosphorylation status of PDK1, PTEN, Akt, c-raf, GSK-3β and Bad in TQ treated cells, thus ratifying the involvement of Akt in apoptosis. Further, the consequential effect of Akt inhibition by TQ is proven by translational repression through deregulated phosphorylation of 4E-BP1, eIF4E, S6R and p70S6K. Significance: Our observations for the first time may provide a new insight for the development of novel therapies for Akt overexpressed breast cancer by TQ.

AB - Aim: Thymoquinone (TQ), the predominant bioactive constituent of black seed oil (Nigella Sativa), has been shown to possess antineoplastic activity against multifarious tumors. However, the meticulous mechanism of TQ on Akt mediated survival pathway is still unrevealed in breast cancer. Here, we investigated TQ's mechanism of action against PI3K/Akt signaling and its downstream targets by modulating proteins translational machinery, leading to apoptosis in cancer cells. Main methods: MDA-MB-468 and T-47D cells were treated with TQ and evaluated for its anticancer activity through phase distribution and western blot. Modulatory effects of TQ on Akt were affirmed through kinase and drug potential studies. Key findings: Studies revealed G1 phase arrest till 24 h incubation with TQ while extended exposure showed phase shift to subG1 indicating apoptosis, supported by suppression of cyclin D1, cyclin E and cyclin dependent kinase inhibitor p27 expression. Immunoblot and membrane potential studies revealed mitochondrial impairment behind apoptotic process with upregulation of Bax, cytoplasmic cytochrome c and procaspase-3, PARP cleavage along with Bcl-2, Bcl-xL and survivin downregulation. Moreover, we construed the rationale behind mitochondrial dysfunction by examining the phosphorylation status of PDK1, PTEN, Akt, c-raf, GSK-3β and Bad in TQ treated cells, thus ratifying the involvement of Akt in apoptosis. Further, the consequential effect of Akt inhibition by TQ is proven by translational repression through deregulated phosphorylation of 4E-BP1, eIF4E, S6R and p70S6K. Significance: Our observations for the first time may provide a new insight for the development of novel therapies for Akt overexpressed breast cancer by TQ.

UR - http://www.scopus.com/inward/record.url?scp=84887098861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887098861&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2013.09.009

DO - 10.1016/j.lfs.2013.09.009

M3 - Article

VL - 93

SP - 783

EP - 790

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 21

ER -